Funding
Series B · Healthtech

Aqua Medical secures Series B for diabetes clinical program

Relevance Ventures led financing to complete the RESTORE-1 pilot study and prepare a planned US pivotal trial.

By RoundOS Funding desk

The amount was not disclosed. The investor announced the financing on September 23, followed by Aqua Medical’s announcement the next day.

Aqua’s investigational PIMA procedure treats targeted tissue in the small intestine using radiofrequency-generated vapor delivered through an endoscope. The planned pivotal trial remains subject to regulatory authorization.

Use of funds

Complete RESTORE-1 pilot study

Prepare planned US pivotal trial

Funding history

Series B · This roundUndisclosed

Sources

  1. Financing announcementprnewswire.com · Sep 23, 2026
  2. aquaendoscopy.com

Similar rounds

All Healthtech rounds →
Abby Care

Abby Care trains and supports eligible family members as paid caregivers, combining nurse-led care management with software that documents care at home.

$82MSeries C · Oct 15, 2026
Confido Health

Confido Health automates patient access and administrative workflows for medical and dental practices.

$12.5MSeries A extension · Oct 14, 2026
Quick

Quick develops AI tools that help emergency dispatchers handle Japan’s 119 calls.

UndisclosedCapital and business alliance agreement · Oct 13, 2026
Suki

Suki develops AI software that helps clinicians document visits and healthcare technology vendors embed clinical assistance in their products.

$90MSeries E · Oct 13, 2026

Related